PRESS RELEASE
News
-
-
PRESS RELEASE
CBI continues to implement its ACE strategy during December 2025
CBI continues to implement its ACE strategy during December 2025, maintaining stable mining returns in Bitcoins and exceeding 13% per annum in USD. The company aims to expand its server fleet and remains focused on holding Bitcoins for potential market rebound -
-
-
PRESS RELEASE
DriX H-9 drone: Exail announces two new orders, one of which integrates aerial anti-drone capabilities
Exail announces signing of two contracts for its DriX H-9 surface drone, accelerating adoption of autonomous solutions in maritime defense and security. CUAS capability for countering air threats and SHOM order for seabed mapping highlight system's versatility and operational relevance -
PRESS RELEASE
Newron Pharmaceuticals S.p.A.: EA Pharma, a subsidiary of Eisai, Announces the Initiation of its Phase III Clinical Trial with Evenamide, a Novel Treatment for Schizophrenia, in Japan
Newron Pharmaceuticals S.p.A. announces Phase III Clinical Trial initiation with Evenamide, a novel Schizophrenia treatment in Japan, led by EA Pharma, a subsidiary of Eisai -
-
-
-
